Todd A. Verdoorn - Net Worth and Insider Trading
Todd A. Verdoorn Net Worth
The estimated net worth of Todd A. Verdoorn is at least $8,140 dollars as of 2024-09-20. Todd A. Verdoorn is the Chief Scientific Officer of DiaMedica Therapeutics Inc and owns about 2,000 shares of DiaMedica Therapeutics Inc (DMAC) stock worth over $8,140. Details can be seen in Todd A. Verdoorn's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Todd A. Verdoorn has not made any transactions after 2018-12-11 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Todd A. Verdoorn
Todd A. Verdoorn Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Todd A. Verdoorn owns 1 companies in total, including DiaMedica Therapeutics Inc (DMAC) .
Click here to see the complete history of Todd A. Verdoorn’s form 4 insider trades.
Insider Ownership Summary of Todd A. Verdoorn
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| DMAC | DiaMedica Therapeutics Inc | 2018-12-11 | Chief Scientific Officer |
Todd A. Verdoorn Latest Holdings Summary
Todd A. Verdoorn currently owns a total of 1 stock. Todd A. Verdoorn owns 2,000 shares of DiaMedica Therapeutics Inc (DMAC) as of December 11, 2018, with a value of $8,140.
Latest Holdings of Todd A. Verdoorn
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| DMAC | DiaMedica Therapeutics Inc | 2018-12-11 | 2,000 | 4.07 | 8,140 |
Holding Weightings of Todd A. Verdoorn
Todd A. Verdoorn Form 4 Trading Tracker
According to the SEC Form 4 filings, Todd A. Verdoorn has made a total of 0 transactions in DiaMedica Therapeutics Inc (DMAC) over the past 5 years. The most-recent trade in DiaMedica Therapeutics Inc is the acquisition of 1,000 shares on December 11, 2018, which cost Todd A. Verdoorn around $4,000.
Insider Trading History of Todd A. Verdoorn
- 1
Todd A. Verdoorn Trading Performance
GuruFocus tracks the stock performance after each of Todd A. Verdoorn's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Todd A. Verdoorn is -7.24%. GuruFocus also compares Todd A. Verdoorn's trading performance to market benchmark return within the same time period. The performance of stocks bought by Todd A. Verdoorn within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Todd A. Verdoorn's insider trading performs compared to the benchmark.
Performance of Todd A. Verdoorn
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -1.39 | | | | | |
| Relative Return to S&P 500(%) | 0.15 | | | | | |
Todd A. Verdoorn Ownership Network
Todd A. Verdoorn Owned Company Details
What does DiaMedica Therapeutics Inc do?
Who are the key executives at DiaMedica Therapeutics Inc?
Todd A. Verdoorn is the Chief Scientific Officer of DiaMedica Therapeutics Inc. Other key executives at DiaMedica Therapeutics Inc include 10 percent owner Koch Thomas Von , 10 percent owner Jan Stahlberg , and CFO and Secretary Scott Kellen .
DiaMedica Therapeutics Inc (DMAC) Insider Trades Summary
Over the past 18 months, Todd A. Verdoorn made no insider transaction in DiaMedica Therapeutics Inc (DMAC). Other recent insider transactions involving DiaMedica Therapeutics Inc (DMAC) include a net purchase of 527,114 shares made by David J. Wambeke , a net purchase of 2,670,588 shares made by Koch Thomas Von , and a net purchase of 1,200,000 shares made by Jan Stahlberg .
In summary, during the past 3 months, insiders sold 0 shares of DiaMedica Therapeutics Inc (DMAC) in total and bought 2,400,000 shares, with a net purchase of 2,400,000 shares. During the past 18 months, 0 shares of DiaMedica Therapeutics Inc (DMAC) were sold and 4,536,639 shares were bought by its insiders, resulting in a net purchase of 4,536,639 shares.
DiaMedica Therapeutics Inc (DMAC)'s detailed insider trading history can be found in Insider Trading Tracker table.
DiaMedica Therapeutics Inc Insider Transactions
Todd A. Verdoorn Mailing Address
Above is the net worth, insider trading, and ownership report for Todd A. Verdoorn. You might contact Todd A. Verdoorn via mailing address: 2 Carlson Parkway, Suite 260, Minneapolis Mn 55447.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
